NasdaqGS - Nasdaq Real Time Price USD
Immunocore Holdings plc (IMCR)
37.25
-0.77
(-2.03%)
At close: June 6 at 4:00:01 PM EDT
37.30
+0.05
+(0.13%)
After hours: June 6 at 4:05:49 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 11 | 13 |
| Avg. Estimate | -0.22 | -0.27 | -0.66 | -1.41 |
| Low Estimate | -0.52 | -0.69 | -1.87 | -3.09 |
| High Estimate | -0.01 | -0.07 | -0.09 | -0.1 |
| Year Ago EPS | -0.23 | 0.17 | -1.02 | -0.66 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 14 | 15 |
| Avg. Estimate | 92.43M | 95.26M | 378.26M | 406.52M |
| Low Estimate | 90.2M | 91.11M | 367.11M | 370.63M |
| High Estimate | 97.34M | 101.08M | 394.15M | 458.52M |
| Year Ago Sales | 75.4M | 80.25M | 310.2M | 378.26M |
| Sales Growth (year/est) | 22.58% | 18.71% | 21.94% | 7.47% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.52 | -0.34 | -0.2 | -0.4 |
| EPS Actual | -0.23 | 0.17 | -0.47 | 0.1 |
| Difference | 0.29 | 0.51 | -0.27 | 0.5 |
| Surprise % | 55.81% | 150.16% | -132.40% | 125.15% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.22 | -0.27 | -0.66 | -1.41 |
| 7 Days Ago | -0.22 | -0.27 | -0.67 | -1.47 |
| 30 Days Ago | -0.4 | -0.42 | -1.61 | -2.01 |
| 60 Days Ago | -0.39 | -0.41 | -1.63 | -2.05 |
| 90 Days Ago | -0.39 | -0.41 | -1.6 | -2.07 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 2 | 1 |
| Up Last 30 Days | 1 | 2 | 1 | 2 |
| Down Last 7 Days | 1 | -- | 2 | -- |
| Down Last 30 Days | 1 | 1 | 10 | 5 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IMCR | 4.17% | -257.00% | 34.85% | -112.10% |
| S&P 500 | 13.13% | 2.48% | 7.55% | 14.01% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/2/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 5/8/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 4/14/2025 |
| Reiterates | Needham: Buy to Buy | 4/10/2025 |
| Maintains | Mizuho: Neutral to Neutral | 4/7/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/12/2025 |
Related Tickers
IMTX Immatics N.V.
5.97
+3.29%
IDYA IDEAYA Biosciences, Inc.
21.73
+2.99%
CNTA Centessa Pharmaceuticals plc
11.92
+0.51%
BCAX Bicara Therapeutics Inc.
11.50
+4.26%
CGEM Cullinan Therapeutics, Inc.
9.08
+3.89%
VRDN Viridian Therapeutics, Inc.
14.68
+3.09%
SRRK Scholar Rock Holding Corporation
34.23
-0.06%
DSGN Design Therapeutics, Inc.
4.0100
+0.25%
KURA Kura Oncology, Inc.
6.73
+2.44%
IMVT Immunovant, Inc.
16.77
+4.68%